| ● | positive cumulative pre-tax earnings over the prior three -year period ended December 31, 2017 |
| ● | growth in net interest income, stable non-interest income trends, and lower non-interest expense trends |
| ● | improvement in asset quality which increases management ’s ability to forecast future taxable income and achieve forecasted results |
| ● | the Company ’s net operating loss (“NOLs”) carryforwards do not begin to expire until 2032, and |
| ● | the Bank ’s Consent Order was terminated in the fourth quarter of 2017 |
| 201 7 | 201 6 | 20 1 5 | ||||||||||
| (in thousands) | ||||||||||||
| Current | $ | — | $ | 21 | $ | — | ||||||
| Deferred | 2,523 | 2,771 | 5,258 | |||||||||
| Net operating loss | (647 | ) | (4,009 | ) | (5,975 | ) | ||||||
| Change in federal statutory rate | 20,274 | — | — | |||||||||
| Change in valuation allowance | (54,049 | ) | 1,238 | 717 | ||||||||
| $ | (31,899 | ) | $ | 21 | $ | — | ||||||
| 201 7 | 201 6 | 20 1 5 | ||||||||||
| (in thousands) | ||||||||||||
| Federal statutory rate times financial statement income (loss) | $ | 2,294 | $ | (956 | ) | $ | (1,125 | ) | ||||
| Effect of: | ||||||||||||
| V aluation allowance | (54,049 | ) | 1,238 | 717 | ||||||||
| Tax-exempt income | (196 | ) | (211 | ) | (264 | ) | ||||||
| Non -taxable life insurance income | (144 | ) | (146 | ) | (103 | ) | ||||||
| Restricted stock vesting | (121 | ) | — | — | ||||||||
| Change in federal statutory rate | 20,274 | — | — | |||||||||
| Other, net | 43 | 96 | 775 | |||||||||
| Total | $ | (31,899 | ) | $ | 21 | $ | — | |||||
| 201 7 | 201 6 | |||||||
| (in thousands) | ||||||||
| Deferred tax assets: | ||||||||
| Net operating loss carry-forward | $ | 25,645 | $ | 42,094 | ||||
| Allowance for loan losses | 1,723 | 3,139 | ||||||
| O REO write-down | 2,432 | 3,366 | ||||||
| Alternative minimum tax credit carry-forward | 692 | 692 | ||||||
| Net assets from acquisitions | 358 | 674 | ||||||
| Net unrealized loss on securities | 169 | 867 | ||||||
| New market tax credit carry-forward | 208 | 208 | ||||||
| Nonaccrual loan interest | 271 | 481 | ||||||
| Accrued expenses | 172 | 3,860 | ||||||
| Deferred compensation | 277 | 465 | ||||||
| Other | 241 | 360 | ||||||
32,188 | 56,206 | |||||||
| Deferred tax liabilities: | ||||||||
| FHLB stock dividends | 557 | 928 | ||||||
| Fixed assets | 68 | 89 | ||||||
| Deferred loan costs | 152 | 274 | ||||||
| Other | 98 | 866 | ||||||
875 | 2,157 | |||||||
| Net deferred tax assets before valuation allowance | 31,313 | 54,049 | ||||||
| Valuation allowance | — | (54,049 | ) | |||||
| Net deferred tax asset | $ | 31,313 | $ | — | ||||